These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 22645402)
1. ICD deactivation: review of literature and clinical recommendations. Thanavaro JL Clin Nurs Res; 2013 Feb; 22(1):36-50. PubMed ID: 22645402 [TBL] [Abstract][Full Text] [Related]
2. Deactivation of implantable cardioverter-defibrillators at end of life. Pettit SJ; Jackson CE; Gardner RS Future Cardiol; 2013 Nov; 9(6):885-96. PubMed ID: 24180544 [TBL] [Abstract][Full Text] [Related]
3. Original research: deactivation of ICDs at the end of life: a systematic review of clinical practices and provider and patient attitudes. Russo JE Am J Nurs; 2011 Oct; 111(10):26-35. PubMed ID: 21926561 [TBL] [Abstract][Full Text] [Related]
4. EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy. Padeletti L; Arnar DO; Boncinelli L; Brachman J; Camm JA; Daubert JC; Hassam SK; Deliens L; Glikson M; Hayes D; Israel C; Lampert R; Lobban T; Raatikainen P; Siegal G; Vardas P; ; Kirchhof P; Becker R; Cosio F; Loh P; Cobbe S; Grace A; Morgan J; ; Europace; 2010 Oct; 12(10):1480-9. PubMed ID: 20675674 [TBL] [Abstract][Full Text] [Related]
5. Addendum to "Personal and public safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations: a medical/scientific statement from the American Heart Association and the North American Society of Pacing and Electrophysiology": public safety issues in patients with implantable defibrillators: a scientific statement from the American Heart Association and the Heart Rhythm Society. Epstein AE; Baessler CA; Curtis AB; Estes NA; Gersh BJ; Grubb B; Mitchell LB; ; Circulation; 2007 Mar; 115(9):1170-6. PubMed ID: 17287391 [TBL] [Abstract][Full Text] [Related]
6. Defibrillator patients should not be denied a peaceful death. Westerdahl AK; Sutton R; Frykman V Int J Cardiol; 2015 Mar; 182():440-6. PubMed ID: 25597981 [TBL] [Abstract][Full Text] [Related]
7. Deactivation of implantable cardioverter defibrillators in terminal illness and end of life care. Kirkpatrick JN; Gottlieb M; Sehgal P; Patel R; Verdino RJ Am J Cardiol; 2012 Jan; 109(1):91-4. PubMed ID: 21943937 [TBL] [Abstract][Full Text] [Related]
8. Implantable cardiac defibrillators and end-of-life care--time for reflection, deliberation and debate? Sheehan M; Newton PJ; Stobie P; Davidson PM Aust Crit Care; 2011 Nov; 24(4):279-84. PubMed ID: 21676627 [TBL] [Abstract][Full Text] [Related]
9. Patients' experiences of the implantable cardioverter defibrillator (ICD); with a focus on battery replacement and end-of-life issues. Fluur C; Bolse K; Strömberg A; Thylén I Heart Lung; 2013; 42(3):202-7. PubMed ID: 23273655 [TBL] [Abstract][Full Text] [Related]
10. Deactivation of Implantable Cardioverter Defibrillator in Patients With Terminal Diagnoses. Trussler A; Alexander B; Campbell D; Alhammad N; Enriquez A; Chacko S; Garrett T; Simpson C; Redfearn D; Abdollah H; Herx L; Baranchuk A Am J Cardiol; 2019 Oct; 124(7):1064-1068. PubMed ID: 31353003 [TBL] [Abstract][Full Text] [Related]
11. Planning for Deactivation of Implantable Cardioverter Defibrillators at the End of Life in Patients With Heart Failure. Brady DR Crit Care Nurse; 2016 Dec; 36(6):24-31. PubMed ID: 27908943 [TBL] [Abstract][Full Text] [Related]
12. Quality of life and end-of-life issues for older patients with implanted cardiac rhythm devices. Lampert R Clin Geriatr Med; 2012 Nov; 28(4):693-702. PubMed ID: 23101578 [TBL] [Abstract][Full Text] [Related]
13. An updated review of implantable cardioverter/defibrillators, induced anxiety, and quality of life. Bostwick JM; Sola CL Psychiatr Clin North Am; 2007 Dec; 30(4):677-88. PubMed ID: 17938040 [TBL] [Abstract][Full Text] [Related]
14. Patients' perspective on deactivation of the implantable cardioverter-defibrillator near the end of life. Pedersen SS; Chaitsing R; Szili-Torok T; Jordaens L; Theuns DA Am J Cardiol; 2013 May; 111(10):1443-7. PubMed ID: 23490027 [TBL] [Abstract][Full Text] [Related]
15. Do implantable cardioverter defibrillators complicate end-of-life care for those with heart failure? Waterhouse E; Ahmad F Curr Opin Support Palliat Care; 2011 Dec; 5(4):307-11. PubMed ID: 22025091 [TBL] [Abstract][Full Text] [Related]
18. Documented consent process for implantable cardioverter-defibrillators and implications for end-of-life care in older adults. Niewald A; Broxterman J; Rosell T; Rigler S J Med Ethics; 2013 Feb; 39(2):94-7. PubMed ID: 23139392 [TBL] [Abstract][Full Text] [Related]
19. End-of-life decisions in ICD patients with malignant tumors. Kobza R; Erne P Pacing Clin Electrophysiol; 2007 Jul; 30(7):845-9. PubMed ID: 17584265 [TBL] [Abstract][Full Text] [Related]
20. Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy. Maron BJ; Spirito P; Ackerman MJ; Casey SA; Semsarian C; Estes NA; Shannon KM; Ashley EA; Day SM; Pacileo G; Formisano F; Devoto E; Anastasakis A; Bos JM; Woo A; Autore C; Pass RH; Boriani G; Garberich RF; Almquist AK; Russell MW; Boni L; Berger S; Maron MS; Link MS J Am Coll Cardiol; 2013 Apr; 61(14):1527-35. PubMed ID: 23500286 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]